Lupin Limited has informed the Exchange regarding a press release dated October 24, 2025, titled "Lupin Launches Authorized Generic Version of Ravicti® in the United States".
Press Release Oct 24 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Kenox Pharmaceuticals Appoints Dr. Julianne Berry as Vice President of R&D and Manufacturing
- Press Release Oct 13 2025
- Lupin Announces Presentation of Phase 1 Data on LNP3693 (STING agonist) at the ESMO Congress 2025
- Press Release Oct 09 2025
- Lupin Unveils Strategic Partnership Program to Expand Reach of its Long-Acting Injectable Platform
Later from Lupin
- Governor Murphy and Local Leaders Attend Ribbon-Cutting Ceremony, Marking the Inauguration of Lupin's New Corporate Offices in Bridgewater
- Press Release Oct 28 2025
- Press Release Oct 30 2025
- Press Release Nov 05 2025
- Press Release Nov 06 2025
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin